Management of Severe Iron Deficiency Anemia with Inadequate Response to Oral Iron
This patient requires immediate transition to intravenous iron therapy given the severe anemia (hemoglobin 7.7 g/dL), profound iron depletion (ferritin 13 ng/mL, transferrin saturation 5.6%), and likely inadequate response to current oral therapy. 1
Immediate Assessment Required
Check hemoglobin response to current oral iron therapy:
- If the patient has been on Ferrex for ≥2 weeks without at least a 10 g/L (1.0 g/dL) rise in hemoglobin, this predicts treatment failure with 90.1% sensitivity and indicates need for IV iron 1
- The current hemoglobin of 7.7 g/dL with such profound iron depletion (ferritin 13 ng/mL, TSAT 5.6%) suggests either non-compliance, malabsorption, ongoing blood loss, or true oral iron failure 2
Transition to Intravenous Iron Therapy
Intravenous iron is indicated for this patient based on:
- Severe anemia with hemoglobin <8 g/dL requiring rapid correction 1
- Profound absolute iron deficiency (ferritin <15 ng/mL, TSAT <6%) 1
- Likely inadequate response to oral therapy given the severity of depletion 1
IV iron formulations to consider:
- Ferric carboxymaltose or ferric derisomaltose are preferred options allowing high-dose administration 1
- These produce clinically meaningful hemoglobin response within 1 week 1
- IV iron is significantly more effective than continued oral therapy when oral iron has failed 1
Investigate Underlying Cause
Comprehensive gastrointestinal evaluation is mandatory:
- Both upper endoscopy (with small bowel biopsy) and colonoscopy should be performed to identify the source of ongoing blood loss 2
- 90% of patients should undergo bidirectional endoscopy unless a definitive cause is identified with the first test 2
- Test for celiac disease (tissue transglutaminase antibody) and Helicobacter pylori during upper endoscopy 2, 3
Assess for malabsorption:
- History of bariatric surgery, inflammatory bowel disease, or chronic diarrhea would favor IV iron as first-line 1
- Atrophic gastritis (autoimmune or H. pylori-related) impairs iron absorption 4
Evaluate for ongoing blood loss:
- Detailed menstrual history if female 5
- NSAID or anticoagulant use 5
- Occult gastrointestinal bleeding requiring endoscopic evaluation 2
Consider Blood Transfusion
Transfusion may be necessary if:
- The patient has severe symptomatic anemia with circulatory compromise (dyspnea at rest, chest pain, tachycardia, hypotension) 1
- Target hemoglobin 70-90 g/L (7.0-9.0 g/dL) with transfusion 1
- However, parenteral iron should be strongly considered as an alternative before transfusion, as each unit of blood contains only ~200 mg elemental iron, insufficient to replenish stores in severe iron deficiency anemia 1
Monitoring Strategy
After initiating IV iron:
- Recheck hemoglobin at 1 week (expect clinically meaningful response) 1
- Continue monitoring hemoglobin every 4 weeks until normalized 1
- Recheck ferritin and transferrin saturation after hemoglobin normalization 1
After hemoglobin normalization:
- Continue iron therapy for 2-3 months to replenish iron stores 1, 2
- Monitor hemoglobin at 3-month intervals for 1 year, then at 2 years 2
Common Pitfalls to Avoid
- Do not continue oral iron indefinitely without assessing response – lack of hemoglobin rise by 2 weeks predicts failure 1
- Do not defer gastrointestinal investigation – this degree of iron deficiency in an adult warrants endoscopic evaluation regardless of age or sex 2
- Do not interpret the normal MCV (83.3 fL) as excluding iron deficiency – MCV may remain normal early in iron deficiency or with concurrent macrocytic process 5
- Do not assume compliance without verification – poor adherence is common with oral iron due to gastrointestinal side effects 3
- Do not transfuse without considering IV iron first – transfusion provides minimal iron repletion and carries greater risks 1